Perspectum Group plc operates as a commercial-stage precision health company in the United Kingdom and internationally. The company offers AI-driven software that utilizes medical images to provide decision support for the diagnosis, stratification, and monitoring of patients with chronic metabolic diseases, multi-organ pathologies, cancer, and other conditions. Its products include LiverMultiScan, an non-invasive liver test based on a single non-contrast multiparametric magnetic resonance imaging scan; MRCP+, an image processing software; Hepatica, an AI-powered software tool for decision support in liver cancer patients; and CoverScan MD that provides a standardized tool to evaluate symptoms and identify changes in the health of various organs. The company serves pharmaceutical companies and clinicians. Perspectum Group plc was incorporated in 2021 and is headquartered in Oxford, the United Kingdom.